Optimizing Janus kinase inhibitor therapy for ulcerative colitis: a real-world perspective [0.03%]
溃疡性结肠炎Janus激酶抑制剂治疗的优化：真实世界视角
Shintaro Akiyama
Shintaro Akiyama
In real-world clinical practice, 3 Janus kinase (JAK) inhibitors-tofacitinib, filgotinib, and upadacitinib-are now available for the treatment of ulcerative colitis. Emerging real-world evidence highlights distinct efficacy and safety profi...
Treatment patterns and outcomes in patients with steroid-dependent ulcerative colitis in Japan: a claims database study [0.03%]
日本糖皮质激素依赖性溃疡性结肠炎患者的治疗模式和结局：基于理赔数据库的研究
Masayuki Saruta,Takumi Sugiyama,Takumi Tajima et al.
Masayuki Saruta et al.
Background/aims: Guidelines recommend that steroid treatment for ulcerative colitis (UC) is tapered or withdrawn within 3 months of initiation, and thiopurine treatment or advanced therapy is administered for steroid-depe...
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a post hoc analysis of safety and effectiveness in older (≥65 years) and younger ( [0.03%]
托法替尼治疗溃疡性结肠炎患者上市后监测的后验安全性与疗效分析：老年（≥65 岁）和年轻（
Katsuyoshi Matsuoka,Takayuki Yamamoto,Minoru Matsuura et al.
Katsuyoshi Matsuoka et al.
Background/aims: To assess, post hoc, tofacitinib safety/effectiveness in patients with ulcerative colitis (UC), stratified by age, using data from a 60-week post-marketing surveillance (PMS) study in Japan. ...
Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey" [0.03%]
关于“5氨基水杨酸在8个亚洲地区溃疡性结肠炎管理中的作用：一项针对医师的调查”的评论
Julajak Limsrivilai,Wai Keung Leung
Julajak Limsrivilai
Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey" [0.03%]
关于“水杨酸氨乙磺酸在八大亚洲地区溃疡性结肠炎管理中的作用：一项对医生的调查”的评论
Tsutomu Nishida,Takahiro Amano,Naoto Osugi et al.
Tsutomu Nishida et al.
Elevated IL-6 levels in the intestinal mucosa of patients with gastrointestinal Behçet's disease [0.03%]
肠道黏膜中IL-6水平升高与胃肠道贝赫切特病有关
Jihye Park,Arjun Ravi,Katharina Bruzelius et al.
Jihye Park et al.
The impact of the quality improvement program on Clostridioides difficile infection management: a quasi-experimental study [0.03%]
一项关于质控计划对艰难梭菌感染管理影响的准实验研究
Jung Yun Lee,Jae-Ki Choi,Tae-Geun Gweon et al.
Jung Yun Lee et al.
Background/aims: Clostridioides difficile infection (CDI) is a major cause of nosocomial diarrhea. This study aimed to implement a quality improvement program to expedite proper CDI treatment, including discontinuing laxa...
Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn's disease: results from an international survey [0.03%]
Lémann指数用于测量克罗恩病病情进展和肠道损害的知识及可接受性：一项国际调查的结果
Charlotte Wong,Johan Burisch,Ryan C Ungaro et al.
Charlotte Wong et al.
Background/aims: Crohn's disease (CD) progresses to structural bowel damage (SBD). The Lémann Index (LI) captures stricture extent/severity, penetrating disease and surgery as a SBD score, and is earmarked for future CD ...
Practices and perceptions of 5-aminosalicylic acid use in Crohn's disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team [0.03%]
韩国克罗恩病5-氨基水杨酸使用实践及认知的全国医师调查(KASID指南工作组)
June Hwa Bae,Seung Yong Shin,Dong Hyun Kim et al.
June Hwa Bae et al.
Background/aims: Despite international guidelines recommending against the use of 5-aminosalicylic acid (5-ASA) for Crohn's disease (CD), it remains widely prescribed. This study aimed to investigate current patterns of 5...
Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies [0.03%]
亚洲老年人群炎症性肠病的临床特点和治疗策略
Jiyoung Yoon,Daein Kim,You Sun Kim
Jiyoung Yoon
The incidence and prevalence of elderly-onset inflammatory bowel disease (EO-IBD) are increasing worldwide. The rising incidence of EO-IBD in Asia is driven by rapid industrialization and an aging population. Older patients often have multi...